HAEM5:Aggressive NK-cell leukaemia: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Rabail.Aslam (talk | contribs) No edit summary |
Rabail.Aslam (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Shanelle De Lancy, MD, Rabail Aslam, MD, Shashirekha Shetty, PhD | |||
Case Western Reserve University, Cleveland, OH | Case Western Reserve University, Cleveland, OH | ||
| Line 20: | Line 20: | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
Aggressive NK-cell leukaemia | |||
==Definition / Description of Disease== | ==Definition / Description of Disease== | ||
Aggressive NK-cell leukaemia is a malignant proliferation of NK-cells, often associated with EBV infection, however, a subset of cases could be EBV negative. The disease has an extremely aggressive clinical course with poor response to chemotherapy, frequent relapses noted in patient who have had previously achieved complete remission (+/- bone marrow transplantation). | |||
==Synonyms / Terminology== | ==Synonyms / Terminology== | ||
Aggressive NK-cell leukaemia/lymphoma | |||
==Epidemiology / Prevalence== | ==Epidemiology / Prevalence== | ||